Foscarnet: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections
AJ Wagstaff, HM Bryson - Drugs, 1994 - Springer
Synopsis The DNA polymerase of human herpes viruses, including cytomegalovirus (CMV),
and the reverse transcriptase of human immunodeficiency virus (HIV) are selectively …
and the reverse transcriptase of human immunodeficiency virus (HIV) are selectively …
Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis
P Chrisp, SP Clissold - Drugs, 1991 - Springer
Synopsis The pyrophosphate analogue, foscarnet, selectively inhibits the DNA polymerase
of human herpes viruses, including cytomegalovirus, and the reverse transcriptase of HIV …
of human herpes viruses, including cytomegalovirus, and the reverse transcriptase of HIV …
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome
MA Jacobson, JJ O'Donnell, J Mills - Antimicrobial agents and …, 1989 - Am Soc Microbiol
Ten patients with acquired immunodeficiency syndrome with newly diagnosed
cytomegalovirus (CMV) retinitis were treated with an induction regimen of intravenous …
cytomegalovirus (CMV) retinitis were treated with an induction regimen of intravenous …
Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus
J Sjövall, A Karlsson, S Ogenstad… - Clinical …, 1988 - Wiley Online Library
Six patients with human immunodeficiency virus were given foscarnet in oral solution, 4000
mg every 6 hours for 3 days, followed by a washout period for 2 days and continuous …
mg every 6 hours for 3 days, followed by a washout period for 2 days and continuous …
Effect of foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS
MA Jacobson, S Crowe, J Levy, F Aweeka… - The Journal of infectious …, 1988 - JSTOR
Materials and Methods Foscarnet therapy. We treated 11 patients with AIDS and
cytomegalovirus retinitis (diagnosed by typical funduscopic appearance) with an induction …
cytomegalovirus retinitis (diagnosed by typical funduscopic appearance) with an induction …
Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled …
WD Hardy - The American journal of medicine, 1992 - Elsevier
Herpes simplex virus (HSV) resistant to acyclovir can produce persistent mucocutaneous
ulcerative disease in patients with the acquired immunodeficiency syndrome (AIDS). The …
ulcerative disease in patients with the acquired immunodeficiency syndrome (AIDS). The …
Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates
JW Mellors, HZ Bazmi, RF Schinazi… - Antimicrobial agents …, 1995 - Am Soc Microbiol
Foscarnet (phosphonoformic acid) is a pyrophosphate analog that inhibits the replication of
human immunodeficiency virus type 1 (HIV-1) in vitro and in patients with AIDS. HIV-1 …
human immunodeficiency virus type 1 (HIV-1) in vitro and in patients with AIDS. HIV-1 …
Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant …
O Ringden, B Lönnqvist, T Paulin… - Journal of …, 1986 - academic.oup.com
Fifty seven episodes of severe cytomegalovirus (CMV) infection were treated with iv
foscarnet in 13 bone marrow and 33 renal graft recipients. The ranges of the daily dose …
foscarnet in 13 bone marrow and 33 renal graft recipients. The ranges of the daily dose …
Acyclovir-resistant herpes in AIDS treated with foscarnet.
MM Youle, DA Hawkins, P Collins - 1988 - cabidigitallibrary.org
This short letter describes the unfortunate sequence of events in a young woman initially
treated successfully for primary herpes simplex virus (HSV) with iv acyclovir (5 mg/kg 3 times …
treated successfully for primary herpes simplex virus (HSV) with iv acyclovir (5 mg/kg 3 times …
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS
AG Palestine, MA Polis, MD De Smet… - Annals of internal …, 1991 - acpjournals.org
▪ Objective: To evaluate foscarnet sodium in treating cytomegalovirus retinitis in patients with
AIDS.▪ Patients: Twenty-four previously untreated persons with AIDS and cytomegalovirus …
AIDS.▪ Patients: Twenty-four previously untreated persons with AIDS and cytomegalovirus …
相关搜索
- pharmacokinetic properties immunocompromised patients
- pharmacokinetic properties therapeutic use
- therapeutic use immunocompromised patients
- pharmacokinetic properties viral infections
- viral infections immunocompromised patients
- viral infections therapeutic use
- foscarnet in the treatment cytomegalovirus infections
- patients with aids foscarnet therapy
- pharmacokinetic properties cytomegalovirus retinitis
- cytomegalovirus retinitis immunocompromised patients
- cytomegalovirus retinitis therapeutic use